Stock listing

Frankfurt:OND Oncopeptides AB Aktie

German listing (Frankfurt) of Oncopeptides AB · home listing Stockholm:ONCO

Follow Oncopeptides AB into a list and get an email when it puts out news.

Share price · FWB:OND

€0.154 EUR +0.010 (+6.7%)

Close on Oct 30, 2026

Day range
€0.154 – €0.154 EUROct 30, 2026
Market cap
€58.88M EURAt the close on Oct 30, 2026 · price × 381.4M shares outstanding
Oncopeptides AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ONCO · Home1.656 SEK-0.017 (-1.0%)2,060,7571.681.6991.6441.673Close on Nov 2, 2026
Frankfurt:OND€0.154 EUR+0.010 (+6.7%)—€0.154€0.154€0.154€0.145Close on Oct 30, 2026
Ticker
Frankfurt:OND
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Oncopeptides (Stockholm:ONCO) Q2 2026 Earnings Call

    Thu, Aug 27, 2026 · 3:00 AM ET

    Watch Transcript
  • Oncopeptides (Stockholm:ONCO) Q1 2026 Earnings Call

    Wed, May 13, 2026 · 3:00 AM ET

    Watch Transcript
  • Oncopeptides (Stockholm:ONCO) Q4 2025 Earnings Call

    Thu, Feb 19, 2026 · 3:00 AM ET

    Watch Transcript

Latest news

All Oncopeptides AB news

Decks

Oncopeptides AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
7 in the last 12 months · 7 in all · newest May 26, 2026 · oldest 2026
Calls
10 calls with a replay · 10 with a transcript · latest Aug 27, 2026
Decks
13 decks · latest Aug 27, 2026

Where Oncopeptides AB is listed

ListingExchangeCountryCurrency
Stockholm:ONCO · Home listingStockholmSwedenSEK
LS Exchange:A2DLU2LS ExchangeGermanyEUR
LSIN:0RN4LSINUnited KingdomSEK
gettex:ONDgettexGermanyEUR
Aquis:ONCOSAquisUnited KingdomSEK
Lang & Schwarz:A2DLU2Lang & SchwarzGermanyEUR
Stuttgart:ONDStuttgartGermanyEUR
Aquis:ONCOSAquisUnited KingdomSEK
Dusseldorf:ONDDusseldorfGermanyEUR
Frankfurt:OND · This pageFrankfurtGermanyEUR
Turquoise:ONCOSTurquoiseUnited KingdomSEK
Munich:ONDMunichGermanyEUR

Log in to ask 6ix AI your own questions about Oncopeptides AB.